Arrhythmias & electrophysiology
Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology
An erratum to this article was published (Europace, 10 Mar 2026 ↗)
Recommendations
As issued by the authors
ABC framework for AAD therapy: A (Appropriate therapy) where Anti-arrhythmic Drugs (AADs) are the best option; B (Backup therapy) as adjunct to invasive procedures such as catheter ablation; C (Complementary therapy) in combination with other therapies
Pharmacological management remains essential, particularly in patients with cardiac implantable electronic devices or channelopathies, where ablation is often not suitable
Emphasis on pro-arrhythmia risk mitigation
Original publication
Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology. Europace. Published 30 March 2025. doi:10. 1093/ europace/ euaf076
Composed by AI from the published abstract and checked against it. How Briefs are made →